Automatic Website Traffic Generator


US   France   Germany   Spain   Netherlands  

DEA Designates Syndros as Schedule II Drug | Latest News

DEA awards Schedule II classification to synthetic THC drug

the FDA recommended to the DEA to schedule Syndros as a Schedule II drug. Syndros uses a synthetic version of tetrahydrocannabinol (THC), the compound associated with the psychoactive effects of cannabis, unlike other cannabis extracts, such as cannabidiol ... read more

DEA OKs synthetic marijuana for pharma company that spent $500,000 to keep pot illegal

Syndros is a synthetic ... for abuse." Other Schedule II drugs include cocaine, morphine and many prescription painkillers. Whole-plant marijuana remains in Schedule I of the CSA, an even stricter regulatory category that designates a lack of medically ... read more

Insys: Syndros Missteps And Even More Subsys Arrests

Syndros' DEA's decision fell short of the Schedule III rating that investors really wanted as drug is labeled Schedule II. Yet another doctor arrest is announced on March 24, continuing to reaffirm our thesis that Subsys is going to be too worrisome to ... read more

A New Marijuana Medicine Gets DEA Scheduling, but It's Not All Good News

This week, the DEA finally announced that it's labeling Syndros as a Schedule II drug, and while that scheduling clears the way for Insys Therapeutics to begin marketing it, the DEA's decision fell short of the Schedule III rating that investors really wanted. read more

DEA Schedules Insys Therapeutics’ Syndros (dronabinol oral solution) as Schedule II Drug

("Insys" or the “Company") today announced that the Drug Enforcement Agency (“DEA”) has issued an interim final rule that would result in Syndros™ (dronabinol oral solution) being placed in Schedule II of the Controlled Substances Act. On July ... read more

Insys Therapeutics Syndros Gets Final DEA Rule (INSY)

announced that the Drug Enforcement Agency (DEA) has issued an interim final rule that would classify its long-approved oral drug, Syndros (dronabinol), as a Schedule II drug under the Controlled Substances Act. Schedule II substances have a high potential ... read more

A pharma company that spent $500,000 trying to keep pot illegal just got DEA approval for synthetic marijuana

The DEA approval places Syndros and its generic formulations in Schedule II ... drugs include cocaine, morphine and many prescription painkillers. Whole-plant marijuana remains in Schedule I of the CSA, an even stricter regulatory category that designates ... read more
Popular RSS Feeds: webhostingtalk best news apps home security system how to use rowing machine safaree samuels addanime steak and cms calendar usc tuition coffee service what is piracy peach tree servicepro carroll college clear creek county christopher guest alternatives to college austin movers classic party rentals sf university of louisiana sayville ferry sylectus


Buy AutoTrafficRSS script now for $27 only!

We will send the script to your PayPal email within few hours,
Please add FullContentRSS@gmail.com to your email contact.



Auto Traffic generator Powered by. Full RSS Feed | Article Generator | Contact Us